STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma

The development of clinical agents remains a costly and time-consuming process. Although identification of new uses of existing drugs has been recognized as a more efficient approach for drug discovery than development of novel drugs, little screening of drugs that might be used for a rare malignant...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Int J Oncol
Main Authors: Oi, Toru, Asanuma, Kunihiro, Matsumine, Akihiko, Matsubara, Takao, Nakamura, Tomoki, Iino, Takahiro, Asanuma, Yumiko, Goto, Mikinobu, Okuno, Kazuma, Kakimoto, Takuya, Yada, Yuki, Sudo, Akihiro
Formáid: Artigo
Teanga:Inglês
Foilsithe: D.A. Spandidos 2016
Ábhair:
Articles
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5117998/
https://ncbi.nlm.nih.gov/pubmed/27840900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2016.3757
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla